| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8679623 | Thrombosis Research | 2018 | 6 Pages |
Abstract
Patients treated with rivaroxaban had lower rate of PTS and better HRQoL after DVT compared to patients treated with warfarin. However, these results should be interpreted with caution due to the limitation imposed by study design.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
K.K. Utne, A. Dahm, H.S. Wik, L.P. Jelsness-Jørgensen, P.M. Sandset, W. Ghanima,